Lena Innala
Sundsvall Municipality(SE)Rheumatology Consultants(US)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Lymphoma Diagnosis and Treatment, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis(2017)269 cited
- → Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study(2011)231 cited
- → Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study(2014)167 cited
- → Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries(2017)141 cited
- Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.(2008)
- → Correction: The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden(2007)94 cited
- → The PTPN221858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden(2007)93 cited
- → Co-morbidity in patients with early rheumatoid arthritis - inflammation matters(2016)86 cited
- → Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis Is Not Superior to the ACC/AHA Risk Calculator(2018)36 cited
- → Aerobic capacity over 16 years in patients with rheumatoid arthritis: Relationship to disease activity and risk factors for cardiovascular disease(2017)5 cited